Elite Pharmaceuticals, Inc. (ELTP)

Market Cap	468.51M -18.9%
Revenue (ttm)	140.12M +100.2%
Net Income	43.41M
EPS	0.04
Shares Out	1.08B
PE Ratio	12.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	418,929
Open	0.4210
Previous Close	0.4000
Day's Range	0.4100 - 0.4400
52-Week Range	0.3282 - 0.8194
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 30, 2026

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments. It owns, licenses, manufactures, and sales of generic, oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P brand; P...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 68
• Stock Exchange: OTCMKTS
• Ticker Symbol: ELTP